The most popular programs for the Drugs (Pharmaceuticals) Tag http://www.c-spanvideo.org/browse?topic=1103 en-US Copyright 2013, National Cable Satellite Corporation info@c-spanarchives.org (National Cable Satellite Corporation) info@c-spanarchives.org (National Cable Satellite Corporation) Tue, 20 Sep 2011 00:00:00 GMT Wed, 19 Jun 2013 15:47:33 GMT The House Judiciary Subcommittee on Competition held a hearing examining the proposed merger between pharmacy benefit management companies Express Scripts and Medco Health Solutions. Among the issues they addressed were antitrust concerns about the merger, prescription drug costs, and the potential impact on community pharmacies. The proposed merger would create a company involved in about a third of the prescription drug transactions in the U.S. http://www.c-spanvideo.org/program/301656-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301656-1 Tue, 20 Sep 2011 00:00:00 GMT Harriet Washington argues that a growing corporate presence in the medical industry yields dire consequences for patients, as drug development and research is initiated on a for-profit basis. Ms. Washington's contentions of the industry's fiscal motivations include the reported versus the actual cost of bringing a new drug to market, her estimate that the monetary value of gifts given by corporate drug manufacturers to physicians in 2000 was $6 billion, and the restricted nature of medical patents, which, the author contends suppresses research. Harriet Washington showed slides throughout her presentation, and then responded to questions from members of the audience at the University of Georgia in Athens, Georgia. http://www.c-spanvideo.org/program/305728-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/305728-1 Tue, 20 Sep 2011 00:00:00 GMT Paul Offit takes a broad look at the anti-vaccine movement in the United States and its consequences for children and adults. Dr. Offit spoke at the Harvard Club in New York City at an event hosted by the Manhattan Institute. http://www.c-spanvideo.org/program/297920-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/297920-1 Tue, 20 Sep 2011 00:00:00 GMT Dr. Anthony Fauci talked about antibiotic resistance due to to the overuse of antibiotics. He responded to telephone calls and electronic communications. http://www.c-spanvideo.org/program/293385-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/293385-5 Tue, 20 Sep 2011 00:00:00 GMT Michael Willrich examined the smallpox epidemic in America in the early 1900s. The author detailed the government's initiatives to deter the spread of the disease by requiring mandatory vaccinations and instituting "virus squads" that upheld quarantines. Though these measures eventually contained the disease, they also sparked a wave of popular resistance among Americans who perceived them as a threat to their health and to their rights. Mr. Willrich addressed the questions of how far the government should go to protect the people and what happens when the interests of public health collide with religious beliefs and personal conscience. He responded to questions from members of the audience. http://www.c-spanvideo.org/program/300232-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/300232-1 Tue, 20 Sep 2011 00:00:00 GMT Using personal stories of adults who were medicated as children, Ms. Barnett explores the debate over prescribing psychiatric drugs for minors diagnosed with mental health issues. She discussed her findings with [New York Times] columnist and author of [Perfect Madness], Judith Warner. http://www.c-spanvideo.org/program/305955-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/305955-1 Tue, 20 Sep 2011 00:00:00 GMT Arthur Ainsberg talked about his book [Breakthrough: Elizabeth Hughes, the Discovery of Insulin, and the Making of a Medical Miracle] (St. Martin's Press, 2010), which recounts the development of insulin to treat diabetes. The author recounts the case of Elizabeth Hughes, who at eleven-years-old in 1919 was diagnosed with juvenile diabetes and was treated by starvation. Ms. Hughes would be one of the first patients treated with insulin injections due to the discovery of purified insulin from animal pancreases by Canadians Frederick Banting and Charles Best. Dr. Michael Bergman then spoke about the history of the types of insulin and syringes. Their talks were illustrated by slides. A brief video was shown of Jean Ashton and Stephen Edidin of the New York Historical Society talking about the "[Breakthrough] Exhibit" based on the book that they then had on display. A video from dLife featuring Professor Michael Bliss and early users of insulin Bob and Gerald Cleveland as well as many others was also shown. Dr. Jesse Roth commented on the presentations. Then the panelists responded to questions from members of the audience. This was an event at the New York University School of Medicine in New York City. http://www.c-spanvideo.org/program/297735-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/297735-1 Tue, 20 Sep 2011 00:00:00 GMT Mr. Elias discussed his book [The Burzynski Breakthrough: The Most Promising Cancer Treatment -- and the Government's Campaign to Squelch It], published by Lexicos. Dr. Stanislaw Burzynski has claimed to have discovered a treatment for cancer. It has, however, not been approved by the Federal Drug Administration, which has taken the doctor to court for insurance fraud and shipping his treatment across state lines. Dr. Burzynski was acquitted of all charges. The author says that the FDA is prejudiced against the small entrepreneur, and protects the interests of the large pharmaceutical companies. After his remarks he answered questions from the audience. NOTE: The audio quality of this program is poor. http://www.c-spanvideo.org/program/162978-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/162978-1 Tue, 20 Sep 2011 00:00:00 GMT Ms. Rosenberg exposes what goes on behind the scenes in the food and drug industries. With the help of doctors, experts, and researchers, she reveals regulatory lapses and what she calls government complicity in undermining the public health. She discussed her findings with Stephanie Beasley, an associate editor of [FDA Week]. http://www.c-spanvideo.org/program/306479-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/306479-1 Tue, 20 Sep 2011 00:00:00 GMT A panel discussion was held about the settlement Merck made with users of its pain reliever Vioxx, which it withdrew from the market in 2004 because of new studies showing increased cardiovascular risk. Some law professors are arguing that a new and unusual provision in the settlement raises ethical concerns. The panelists discusssed why Merck settled and why the settlement was for so much less than originally anticipated; if the settlement will stand up under legal challenge; comparisons with other settlements; and reform of the system for mass litigation. After the presentations the panelists responded to questions from members of the audience. Mr. Calfee moderated. http://www.c-spanvideo.org/program/203393-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/203393-1 Tue, 20 Sep 2011 00:00:00 GMT Investigative journalist Doug Fine looks at the financial benefits of legalizing cannabis, which he argues would add close to $100 billion to our economy. He showed slides during his presentation and then responded to questions from members of the audience at Harborside Health Center in Oakland, California. http://www.c-spanvideo.org/program/308028-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308028-1 Tue, 20 Sep 2011 00:00:00 GMT Food and Drug Administration (FDA) Commissioner Margaret Hamburg gave her assessment of the problem of counterfeit drugs and talked about what the FDA is doing to combat it. She responded to questions from members of the audience. This was the keynote speech at the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club. Marv Shepherd then gave the closing remarks for the day. http://www.c-spanvideo.org/program/295894-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/295894-4 Tue, 20 Sep 2011 00:00:00 GMT Historian Elaine Tyler May chronicles the history of the birth control pill. Professor May argues that "the Pill" had two mothers: birth control pioneer Margaret Sanger and women's rights activist Katharine McCormick. She argues that the most important change brought about by "the Pill" was for married couples, making it possible for women to plan careers. Elaine May was interviewed by American Enterprise Institute scholar Christina Hoff Sommers. The date and location of this program is not known. http://www.c-spanvideo.org/program/293208-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/293208-1 Tue, 20 Sep 2011 00:00:00 GMT The Partnership for Safe Medicines held a forum on counterfeit prescription drugs. Scott LaGanga opened the discussion with an overview of the issue. Marv Shepherd moderated the panel, which included an AIDS patient who accidentally used counterfeit drugs to treat his symptoms. Following their remarks, panelists responded to audience members' questions. "Who's Getting Hurt by Counterfeit Drugs?" was the opening panel of the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club. http://www.c-spanvideo.org/program/295894-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/295894-1 Tue, 20 Sep 2011 00:00:00 GMT Doctors and officials from Health and Human Services and the Food and Drug Administration testified on the effects of drug shortages on cancer patients. http://www.c-spanvideo.org/program/301725-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301725-1 Tue, 20 Sep 2011 00:00:00 GMT Joy Lovelace testified on the meningitis outbreak earlier in 2012 that killed her husband, Eddie Lovelace, who contracted the disease from a tainted injection. The outbreak was linked to 32 deaths in 19 states, and sickened 440 others, and was traced to a Massachusetts-based pharmacy that manufactured the shots. Ms. Lovelace in her testimony said that no one called to tell her the cause of her husband's death; she found out through the press. http://www.c-spanvideo.org/program/309397-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/309397-1 Tue, 20 Sep 2011 00:00:00 GMT Witnesses testified on the safety of pharmaceuticals made fully or partially abroad. A Government Accountability Office (GAO) report indicated that 80 percent of U.S. drug ingredients, and 40 percent of finished drugs were made abroad. Among the topics addressed were Food and Drug Administration (FDA) rules for drug quality assurance and inspections, tracking systems, and drug recalls. http://www.c-spanvideo.org/program/301530-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301530-1 Tue, 20 Sep 2011 00:00:00 GMT White House and Drug Enforcement Administration officials testified on the problem of prescription drug abuse and proposed solutions. Senator Sherrod Brown also testified on his bill, the "Stop Trafficking of Pills" Act. http://www.c-spanvideo.org/program/299668-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/299668-1 Tue, 20 Sep 2011 00:00:00 GMT Scott Williams and Tim Mackey presented their research on counterfeit drugs. http://www.c-spanvideo.org/program/308446-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-1 Tue, 20 Sep 2011 00:00:00 GMT Panelists talked about who benefits from unsafe drugs. Topics included enforcement and prosecution efforts and difficulties, and the trafficking of controlled prescription drugs such as Oxycontin. The panelists responded to questions from members of the audience. Dr. Bryan Liang moderated. "Who's Benefiting from Unsafe Drugs?" was the second panel of the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club. http://www.c-spanvideo.org/program/295894-2 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/295894-2 Tue, 20 Sep 2011 00:00:00 GMT Gardiner Harris talked about Food and Drug Administration (FDA) estimate that close to 180 important drugs are in short-supply. In response, health providers are being forced to purchase expensive alternative drugs. Guest will discuss the reasons behind the shortfall and some of the proposals for correcting the problem, which include a national stockpiling of select drugs, incentives for increased production of generic drugs and more authority for the FDA to ensure that adequate supplies exist. He responded to telephone calls and electronic communications. http://www.c-spanvideo.org/program/301255-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301255-5 Tue, 20 Sep 2011 00:00:00 GMT The New York Times columnist explores health insurance coverage for behavioral disorders in children, such as ADHD, Asperger's, OCD, bi-polar disorder and dyslexia. She discusses how parents attempt to obtain proper treatment for their children in a health care system that does not seemed designed to handle or pay for treatment for these disorders, in addition to treatment for physical ailments. http://www.c-spanvideo.org/program/292445-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/292445-1 Tue, 20 Sep 2011 00:00:00 GMT Witnesses testified about proposed legislation that would restrict approval and use of antimicrobial drugs for animals. The legislation would ban seven classes of antibiotics important to human health from being used in animals, and would restrict other antibiotics to therapeutic and some preventive uses. Officials called for ending the use of antibiotics for growth promotion in hogs and other livestock, saying the overuse of antibiotics on farms could lead to drugs losing their effectiveness in human medicine. http://www.c-spanvideo.org/program/287677-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/287677-1 Tue, 20 Sep 2011 00:00:00 GMT Government and private sector officials testified on the use of antipsychotic drugs on dementia patients in nursing homes and long term care facilities. The Food and Drug Administration has said these drugs could cause serious or life threatening adverse effects. Topics included staff training, increased familial involvement, and better collaboration and communication during the transfer stage from a hospital to a nursing home or long-term care facility. http://www.c-spanvideo.org/program/302927-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/302927-1 Tue, 20 Sep 2011 00:00:00 GMT Witnesses testified about the approval process for new drugs at the Food and Drug Administration, the recent recall of the medication Vioxx, the safety of drug testing and manufacturers claims, and future public health safety. Among the topics they addressed were pressures, if any, by pharmaceutical companies on the approval process, the safety of other drugs on the market, and recall procedures. http://www.c-spanvideo.org/program/184513-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/184513-1 Tue, 20 Sep 2011 00:00:00 GMT Allan Coukell, deputy director of the Medical Safety Portfolio of the Pew Health Group, talked about the drug safety. Earlier in the week, the House passed the Food and Drug Administration Reform Act of 2012 by a vote of 387-5. This legislation gives the FDA the funding it needs to approve new drugs and medical devices more quickly and improves inspection. The Senate passed a similar bill the previous week and a final draft of legislation is expected early the next month. Mr. Coukell responded to telephone calls and electronic communications. http://www.c-spanvideo.org/program/306374-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/306374-5 Tue, 20 Sep 2011 00:00:00 GMT Obama administration officials unveiled an aggressive plan to curb prescription drug abuse. The plan will include some new federal requirements aimed at educating the medical community about the proper use of prescription drugs. There are four main parts to the administration's initiative: education, monitoring, taking unused prescription drugs back and enforcement of drug laws. http://www.c-spanvideo.org/program/299124-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/299124-1 Tue, 20 Sep 2011 00:00:00 GMT Barry Cadden invoked his Fifth Amendment rights and would not testify at a hearing on the meningitis outbreak earlier in 2012 that was linked to 32 deaths in 19 states, and sickened 440 others. The outbreak was traced to his Massachusetts-based pharmacy that manufactured the contaminated injections. http://www.c-spanvideo.org/program/309397-2 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/309397-2 Tue, 20 Sep 2011 00:00:00 GMT Ray Moynihan talked about the book he co-wrote with Alan Cassels, [Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All into Patients], published by Nation Books. In the book he argued that the world's biggest drug companies now target healthy people by reclassifying the problems of daily life as medical conditions. The author described how physicians are in the habit of prescribing drugs for problems that could be treated with an improved diet and exercise. Mr. Moynihan also asserted that billions of health care dollars are being spent on treating healthy, rich Americans as opposed to fighting the AIDS epidemic and treating the legitimately sick. At the event, Mr. Moynihan gave examples of the problem and some examples of attempts to disentangle the medical profession and the pharmaceutical industry. He suggested that the central problem is the need for new structures for defining what is illness and what is health. He responded to questions from members of the audience and encouraged discussion. http://www.c-spanvideo.org/program/188350-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/188350-1 Tue, 20 Sep 2011 00:00:00 GMT Panelists talked about efforts and progress in fighting counterfeit perscription drugs. They used slides during their presentations, and afterward the panelists responded to questions from members of the audience. Tom Kubic moderated. "Who's Making Progress Against Counterfeit Drugs?" was the third panel of the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club. http://www.c-spanvideo.org/program/295894-3 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/295894-3 Tue, 20 Sep 2011 00:00:00 GMT Catherine Larkin talked about the FDA's drug approval and review processes for current drugs on the market. She responded to telephone calls and electronic communications. Among the topics she addressed were the recall of the diabetes medicine Avandia and the rejection of the weight loss drug, Qnexa. http://www.c-spanvideo.org/program/294663-7 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/294663-7 Tue, 20 Sep 2011 00:00:00 GMT Allan Coukell talked about the Governmental Accountability Office (GAO) report on the make-up of prescription drugs, and he responded to telephone calls and electronic communications. According the findings of the report, up to 80 percent of the chemicals and ingredients in the drugs were made outside the U.S. Mr. Coukell, who testified at a recent Senate hearing on the issue, discussed the oversight of the pharmaceutical industry, and the risk that foreign components in drugs present to individuals in the U.S. http://www.c-spanvideo.org/program/301607-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301607-4 Tue, 20 Sep 2011 00:00:00 GMT Witnesses testified about the safety and adverse side effects of the dietary supplement Ephedra. They also talked about the distribution and marketing of the supplement, as well as charges that companies sold it knowing the potential health risks. Mr. Ellis, Mr. Brown and Mr. Rodriguez refused to answer the committee's questions, invoking their Fifth Amendment privilege. http://www.c-spanvideo.org/program/177533-2 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/177533-2 Tue, 20 Sep 2011 00:00:00 GMT In his book, [Comfortably Numb: How Psychiatry Is Medicating a Nation], Charles Barber contends that Americans are overmedicated with psychiatric drugs and have confused the difference between ordinary problems and mental illness. Mr. Barber argued that pharmaceutical companies are culpable in the desire to medicate. He responded to audience members' questions. Charles Barber is a psychiatry lecturer at the Yale University School of Medicine. He is the author of [Songs from the Black Chair: A Memoir of Mental Illness.] http://www.c-spanvideo.org/program/199864-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/199864-1 Tue, 20 Sep 2011 00:00:00 GMT Merck Pharmaceuticals Chief Executive Officer Kenneth Frazier was interviewed by Alan Murray about health care and the pharmaceutical industry. Among the topics they discussed were the 2010 health care law, Food and Drug Administration drug approval, and the the Penn State sexual abuse case, of which Mr. Frazier was in charge. The program included questions and answers with audience members. http://www.c-spanvideo.org/program/303168-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/303168-1 Tue, 20 Sep 2011 00:00:00 GMT Witnesses testified about medical testing involving gene therapy, a process of using DNA to correct a wide variety of inherited disorders, as well as some forms of cancer and heart disease. Mr. Gelsinger talked about his son who died as a result of the tests. He was followed by two panels of officials and scientists who talked about a variety of topics, including if scientists had been truthful in informing patients of the risks of the therapy and why the F.D.A. and National Institutes of Health had not shared information with each other. http://www.c-spanvideo.org/program/155137-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/155137-1 Tue, 20 Sep 2011 00:00:00 GMT A community prevention manager of the Rhode Island Student Assistance Services and the director of the prescription monitoring program at Brandeis University testified on the problem of prescription drug abuse and discussed proposed solutions. http://www.c-spanvideo.org/program/299668-2 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/299668-2 Tue, 20 Sep 2011 00:00:00 GMT A hearing was held to examine the increasing use of prescription controlled substances by teenagers and others for non-medical purposes, which has been exacerbated by the ease of obtaining them over the Internet. Topics included the nature and cause of the problem, the extent to which the problem originates outside the U.S., how to fight rogue sites without disrupting legitimate sites, and whether current laws can sufficiently address the problem. http://www.c-spanvideo.org/program/206149-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/206149-1 Tue, 20 Sep 2011 00:00:00 GMT Douglas Holtz-Eakin talked about Medicare Part D as part of overall discussions on the debt between President Obama and congressional leaders, and he responded to telephone calls and electronic communications. Part D is the portion of Medicare that deals with prescription drugs. President Obama and Democrats would like to see changes to Part D. Among their proposals is to require drug companies to extend rebates for drugs issued under Medicare Part D. Currently, drug companies only have to issue rebates for drugs under Medicaid. http://www.c-spanvideo.org/program/300671-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/300671-4 Tue, 20 Sep 2011 00:00:00 GMT The Justice Department announced a historical health care fraud settlement with GlaxoSmithKline. The $3 billion settlement was the largest of its kind and resulted from multiple criminal and civil investigations involving the drugs Paxil, Wellbutrin, and Avandia. http://www.c-spanvideo.org/program/306889-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/306889-1 Tue, 20 Sep 2011 00:00:00 GMT Margaret Hamburg gave the keynote address at a conference on counterfeit prescription drugs. She talked about a new campaign to increase consumer and physician awareness of the counterfeit problem. http://www.c-spanvideo.org/program/308446-7 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-7 Tue, 20 Sep 2011 00:00:00 GMT Members of the Food and Drug Administration's Science Board testified about the report, "The FDA Commission at Risk," that they helped write. Topics included the FDA's inability to fulfill its mission because of its eroding scientific base, its negative approach to oversight, and significant budget cuts over the last 35 years. It was recommended that the FDA budget be doubled over the next two years and that the number of personnel be increased by at least 50 percent. Commissioner Andrew Von Eschenbach testified about the FDA's response to the report. Gail Cassell was chair of the FDA Science Board subcommittee that wrote the report. http://www.c-spanvideo.org/program/203822-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/203822-1 Tue, 20 Sep 2011 00:00:00 GMT Subcommittee members held a hearing title "Sick Crime: Counterfeit Drugs in the United States." FDA officials, drug industry representatives, and family members of counterfeit drug victims testified how counterfeit drugs enter the legitimate pharmaceutical market. Among the topics members of the panels spoke about were government regulation of the drug supply line, paper pedigrees, and criminal invesigations. During the first panel, Commissioner Lutter spoke about implementations of stringent license requirements on the state level. He discussed the use of electronic devices and new technologies in the distribution of pharmaceuticals. The second panel talked about Carlos Luis, who bought Epogen and Procrit from a gentleman's club in Miami. He moved the drugs into the wholesale market and the family of Tim Fagan sued a CVS subdiary for distributing Epogen, an anemia drug, after his emergency liver transplant. The third panel spoke about the growth of counterfeit drugs, accreditation of interstate wholesale distribution in states including Indiana, and suggestions to improve capture of criminal distributors. Randall Lutter used charts and graphs during the opening panel. Representative Gutknecht displayed a "scare-ad" regarding drugs purchased in Canada. He also presented a digital chip that could be placed inside medications to identify the ingredients and only costs ten cents. Katherine Eban is the author of [Dangerous Doses: How Counterfeiters are Contaminating America's Drug Supply], published by Harcourt. Mr. Fagan and Mr. Butler are relatives on counterfeit drug victims in Florida. http://www.c-spanvideo.org/program/189682-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/189682-1 Tue, 20 Sep 2011 00:00:00 GMT A hearing was held on the role of the Food and Drug Administration in evaluating the safety of Avandia, a drug used in the treatment of Type 2 diabetes. FDA officials testified about post-marketing surveillance of new drugs and "meta-analysis." Avandia was approved by the FDA in 1999. Dr. Nissen testified about his study linking Avandia use with a 43 percent increased risk of heart attack. Dr. Buse testified about increased cholesterol in Avandia-using patients. Witnesses emphasized the need for earlier studies and more sensitive protocols. Dr. Slaoui testified about GlaxoSmithKline's research and actions. Dr. Buse is also the president-elect for medicine and science of the American Diabetes Association. http://www.c-spanvideo.org/program/198496-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/198496-1 Tue, 20 Sep 2011 00:00:00 GMT Panelists talked about international efforts to investigate counterfeit prescription drug operations. Topics included the difficulties of tracking counterfeit drug shipments and the money involved. This was part of the Partnership for Safe Medicines (PSM) Third Annual Counterfeit Drug Conference, held at the National Press Club. http://www.c-spanvideo.org/program/308446-6 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-6 Tue, 20 Sep 2011 00:00:00 GMT Witnesses testified about prescription drug abuse, access to prescription drugs through physicians, the Internet, and patients, as well as the extent of the problem in the U.S. They also talked about the costs associated with prescription drug abuse including diversion programs, theft and other crimes, law enforcement assets, and addiction support. http://www.c-spanvideo.org/program/193584-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/193584-1 Tue, 20 Sep 2011 00:00:00 GMT Peter Hirth talked about the pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest has invented several drugs including Sutent for kidney cancer and Zelboraf for melanoma. He responded to telephone calls and electronic communications. Mr. Hirth participated from San Francisco. Due to a signal loss, the program ends abruptly, and approximately eight minutes of the program were lost. Part two can viewed using program identification number 302145-101. http://www.c-spanvideo.org/program/302145-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/302145-5 Tue, 20 Sep 2011 00:00:00 GMT John Roth, Director of the U.S. Food and Drug Administration's Office of Criminal Investigations talked about the resources at FDA's disposal for combating counterfeit drugs, the criteria for an investigation, and the processes involved. http://www.c-spanvideo.org/program/308446-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-4 Tue, 20 Sep 2011 00:00:00 GMT Anna Edney talked about the congressional investigation into compounding pharmacies, including the role of the U.S. Food and Drug Administration (FDA) in regulating these pharmacies. A report released by House Democrats found gaps in the oversight of compounding pharmacies across the country. Ms. Edney also responded to telephone calls and electronic communications. A compounding pharmacy is one in which a licensed pharmacist combines or mixes ingredients for a prescription, creating a medication that is tailored to the needs of an individual, but is not necessarily approved by the FDA. http://www.c-spanvideo.org/program/312269-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/312269-5 Tue, 20 Sep 2011 00:00:00 GMT Panelists discussed drug safety and security, including the impact of counterfeit drugs on the industry. They also responded to questions from the audience. http://www.c-spanvideo.org/program/308446-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-5 Tue, 20 Sep 2011 00:00:00 GMT